Molecular histocompatibility typing in unrelated donor bone marrow transplantation

Blood Reviews

Volumn 11, Issue 2, 1997, Pages 105-117

  Madrigal, J A ^a,b   Arguello, R ^a   Scott, I ^a   Avakian, H ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; BONE MARROW TRANSPLANTATION; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY GENE; HISTOCOMPATIBILITY TEST; PRIORITY JOURNAL; REVIEW; TISSUE TYPING;

EID: 0030761970     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-960X(97)90016-3     Document Type: Article

References (101)

1. Thomas ED. Karnofsky Memorial Lecture: Marrow transplantation for malignant diseases. J Clin Oncol 1983; 1: 517-531.
2. O'Reilly RJ. Allogenic bone marrow transplantation: current status and future directions. Blood 1983; 62: 941-964.
3. Bortin MM, Gale RP, Kay HE, Rimm AA. Bone marrow transplantation for acute myelogenous leukemia. Factors associated with early mortality. JAMA 1983; 249: 1166-1175.
4. Goldman JM, Apperley JF, Jones L et al. Bone marrow transplantation for patients with chronic myeloid leukemia. N Engl J Med 1986; 314: 202-207.
5. Gratwohl A, Hermans J, Baldomero H. Blood and marrow transplantation activity in Europe 1995. Bone Marrow Transplant 1997: 19: 407-419.
6. Goldman JM, Gale RP, Horowitz MM et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. Ann Intern Med 1988; 108: 806-814.
7. Clift RA, Appelbaum FR, Thomas ED. Treatment of chronic myeloid leukemia by marrow transplantation. Blood 1993; 82: 1954-1956.
8. Snyder DS, Negrin RS, O'Donnell MR et al. Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase. Blood 1994; 84: 1672-1679.
9. Hows JM, Yin JL, Marsh J et al. Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia. Blood 1986; 68: 1322-1328.
10. McGlave P, Bartsch G, Anasetti C et al. Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program. Blood 1993; 81: 543-550.
11. Hansen JA. HLA and marrow transplants from unrelated donors. Exp Hematol 1993; 22: 677a (Abstr).
12. Marks DI, Cullis JO, Ward KN et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years. Ann Intern Med 1993; 119: 207-214.
13. Hows J, Bradley BA. Gore S, Downie T, Howard M. Gluckman E. Prospective evaluation of unrelated donor bone marrow transplantation. The International Marrow Unrelated Search and Transplant (IMUST) Study. Bone Marrow Transplant 1993; 12: 371-380.
14. Bortin MM, Rimm AA. Increasing utilization of bone marrow transplantation. II. Results of the 1985-1987 survey. Transplantation 1989; 48: 453- 458.
15. Horowitz SD, Bach FH, Groshong T, Hong R, Yunis EJ. Treatment of severe combined immunodeficiency with bone-marrow from an unrelated, mixed-leucocyte-culture-non-reactive donor. Lancet 1975; 2: 431-433.
16. O'Reilly RJ, Dupont B, Pakwa S et al. Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor. N Engl J Med 1977; 297: 1311-1318.
17. Burnett AK. The treatment of acute leukaemia. Lancet 1997; 349: 270-275.
18. 18.The Westminster Hospitals Bone Marrow Transplant Team. Bone-marrow transplant from an unrelated donor for chronic granulomatous disease. Lancet 1977; 1: 210-213.
19. Speck B, Zwaan FE, van Rood JJ, Eernisse JG. Allogeneic bone marrow transplantation in a patient with aplastic anemia using a phenotypically HL-A-identifcal unrelated donor. Transplantation 1973; 16: 24-28.
20. Hansen JA, Clift RA, Thomas ED, Buckner CD, Storb R, Giblett ER. Transplantation of marrow from an unrelated donor to a patient with acute leukemia. N Engl J Med 1980; 303: 565-567.
21. Atkinson K, Horowitz MM, Gale RP et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 1990; 75: 2459-2464.
22. Gale RP, Bortin MM, van Bekkum DW et al. Risk factors for acute graft-versus-host disease. Br J Haematol 1987; 67: 397-406.
23. Bacigalupo A, Gualandi JT, van Lint MT et al. Multivariate analysis of risk factors for survival and relapse in chronic granulocytic leukemia following allogeneic marrow transplantation: impact of disease related variables (Sokal score). Bone Marrow Transplant 1993; 12: 443-448.
24. Ash RC, Casper JT, Chitamber CR et al. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. N Engl J Med 1990; 322: 485-494.
25. Rufer N, Breur VB, Tiercy J-M et al. High-resolution histocompatibility testing of a group of sixteen B44-positive, ABDR serologically matched unrelated donor-recipient pairs. Analysis of serologically undisclosed incompatibilities by cellular techniques, isoelectrofocusing, and HLA oligotyping. Hum Immunol 1993; 38: 235-239.
26. Jordan F, McWhinnie AJ, Turner S et al. Comparison of HLA DRB1 typing and DNA-RFLP, PCR-SSO and PCR-SSP methods and their application in providing matched unrelated donors for bone marrow transplantation. Tissue Antigens 1995; 45: 103-110.
27. Madrigal JA, Scott I, Arguello R et al. Factors influencing the outcome of bone marrow transplants using unrelated donors. Immunol Rev 1997. In press.
28. Tiercy JM, Morel C, Friedel AC et al. Selection of unrelated donors for bone marrow transplantation is improved by HLA class II genotyping with oligonucleotide hybridization. Proc Natl Acad Sci USA 1991: 88: 7121-7125.
29. Goulmy E, Schipper R, Pool J et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 1996; 334: 281-285.
30. Gorer PA. The genetic and antigenic basis of tumor transplantation. J Pathol 1937; 44: 691-697.
31. Snell GD. The genetics of transplantation. J Natl Cancer Inst 1953; 14: 691-700.
32. Lorenz E, Uphoff D, Reid TR, Shelton E, Modification of irradiation injury in mice and guinea pigs by bone marrow injections. J Natl Cancer Inst 1951; 12: 197-201.
33. Dausset J, Nenna A, Brecy H. Leuco-agglutinins. V. Leucoagglutinins in chronic idiopathic or symptomatic pancytopenia and in paroxysmal nocturanal hemoglobinuria. Blood 1954; 9: 696-720.
34. Payne R, Rolfs MR. Fetomaternal leokocyte incompatibility. J Clin Invest 1958; 37: 1756-1763.
35. van Rood JJ, Ernisse JG, van Leeuwen A. Leukocyte antibodies in sera from pregnant women. Nature 1958; 181: 1735-1736.
36. Hanler H, Cleton FJ, Ernisse JF, eds. Histocompatibility Testing. Copenhagen: Munksgaard, 1965.
37. van Rood J, van Leeuwen A, Keuning J, van Oud B, Alblas A. The serological recognition of the human MLC determinants using a modified cytotoxicity technique. Tissue Antigens 1975: 5: 73-79.
38. Parham P, Adams EJ, Arnett KL. The origins of HLA-A,B,C polymorphism. Immunol Rev 1995; 143: 141-180.
39. Bodmer JG, Marsh SGE, Albert ED et al. Nomenclature for factors of the HLA system, 1996. Tissue Antigens 1997; 49: 297-321.
40. Dupont B, Braun Jr DW, Junis EJ, Carpenter CB. HLA-D by cellular typing. In: Terasaki PI, ed. Histocompatibility Testing. Los Angeles: UCLA, 1980: 229-267.
41. Wake C, Long E, Mach B. Allelic polymorphism and complexity of the genes for HLA-DR β-chains: direct analysis by DNA-DNA hybridisation. Nature 1982; 300: 372-374.
42. Bidwell JL, Bignon JD. DNA-RFLP methods and interpretation scheme for HLA-DR and DQ typing. Eur J Immunogenetics 1991; 18: 5-22.
43. Bidwell JL, Bidwell EA, Wood NAP et al. HLA-DR and -DQ typing by DNA-RFLP analysis. In: Hui KM and Bidwell JL, eds. Handbook of HLA Typing Techniques. London: CRC Press, 1993: 71-98.
44. Inoko H, Ota M. PCR-RFLP. In: Hui KM, Bidwell JL, eds. Handbook of HLA Typing Techniques. London: CRC Press, 1993: 9-70.
45. Tatari Z, Fortier C, Bobrynina V et al. HLA-Cw alleles analysis by PCR-restriction fragment length polymorphism: study of known and additional alleles. Proc Natl Acad Sci USA 1995; 92: 8803-8807.
46. Angellini G, du Preval C, Gorki J et al. High resolution analysis of the human HLA-DR polymorphism by hybridisation with sequence specific oligonucleotide probes. Proc Natl Acad Sci USA 1986; 83: 4489-4493.
47. Holbeck SL, Nepom GT. Exon-specific ologonucletide probes localise HLA-BQB allelic polymorphism. Immunogenetics 1986; 24: 251-258.
48. Baxter-Lowe LA. Molecular techniques for typing unrelated marrow donors: potential impact of molecular typing disparity on donor selection. Bone Marrow Transplant 1994; 14(suppl 4): S42-S50.
49. Begovich AB, Erlich HA. HLA typing for bone marrow transplantation. JAMA 1995; 273: 586-591.
50. Bidwell JL. Applications of the polymerase chain reaction to HLA class II typing. Vox Sang 1992; 63: 81-89.
51. Tiercy J-M, Grundschober C, Jeannet M, Mach B. A comprehensive HLA-DRB, -DQB and -DPB oligotyping procedure by hybridisation with sequence-specific oligonucleotide probes. In: Hui KM, Bidwell JL, eds. Handbook of HLA Typing Techniques. London: CRC Press, 1993: 117-148.
52. Date Y, Kimura A, Kato H, Sasazuki T. DNA typing of the HLA-A gene: population study and identification of four new alleles in Japanese. Tissue Antigens 1996: 47: 93-101.
53. Fernandez-Vina M, Lazaro AM, Sun Y et al. Population diversity of B-locus alleles observed by high resolution DNA typing. Tissue Antigens 1995; 45: 153-168.
54. Levine JE, Yang SY. SSOP typing of the Tenth International Histocompatibility Workshop reference cell lines for HLA-C alleles. Tissue Antigens 1194; 44: 174-183.
55. Allen M, Liu L, Gyllensten U. A comprehensive polymerase chain reaction oligonucleotide typing system for HLA class I alleles. Hum Immunol 1994; 40: 25-32.
56. Gao X, Jakobsen IB, Serjeantson SW. Characterisation of the HLA polymorphism by locus specific polymerase chain reaction amplification and oligonucleotide hybridisation. Hum Immunol 1994; 41: 267-279.
57. Kimura A, Sasazuki T. Eleventh International Histocompatibility Workshop reference protocol for HLA DNA-typing technique. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991: Proceedings of the 11th International Histocompatibility Workshop and Conference, vol 1. Oxford: Oxford University Press, 1992: 397-419.
58. Cotton RGH. Current methods of mutation detection. Mutat Res 1993; 285: 125-144.
59. Newton CR, Graham A, Heptinstall LE et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucl Acid Res 1989; 17: 2503-2516.
60. Lo Y M-D, Mehal WZ, Fleming KA et al. Analysis of complex genetic systems by ARMS-SSCP: application to HLA genotyping. Nucl Acid Res 1992; 20: 1005-1009.
61. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225-235.
62. Olerup O, Aldener A, Fogdell A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993; 41: 119-134.
63. Olerup O, Zetterquist H. HLA-DR typing by polymerase chain reaction amplification with sequence-specific primers (PCR-SSP). In: Hui KM, Bidwell JL, eds. Handbook of HLA Typing Techniques. London: CRC Press, 1993: 149-174.
64. Bunce M, O'Neil CM, Barnardo MCNM et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 and DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995; 46: 355-367.
65. Bunce M, Welsh KI. Rapid DNA typing for HLA-C using sequence-specific primers (PCR-SSP): identification of serological and non-serologically defined HLA-C alleles including several new alleles. Tissue Antigens 1994; 43: 7-17.
66. Krausa P, Bodmer JG, Browning MJ. Defining the common subtypes of HLA A9, A10, A28 and A19 by use of ARMS/PCR. Tissue Antigens 1993; 42: 91-99.
67. Krausa P, Brywka III D, Savage D et al. Genetic polymorphism within HLA-A *02: significant allelic variation revealed in different populations. Tissue Antigens 1995; 45: 223-231.
68. Ganguly A, Prockop DJ. Detection of mismatched bases in double stranded DNA by gel electrophoresis. Electrophoresis 1995; 16: 1830-1835.
69. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989; 5: 874-879.
70. Summers C, Fergusson W, Gokhale D, Taylor M. Donor-recipient bone-marrow matching by single strand conformation polymorphism analysis. Lancet 1992; 339: 621.
71. Hoshino S, Kimura A, Fukuda Y et al. Polymerase chain reaction single-strand conformation polymorphism analysis of polymorphism in DPA1 and DPB1 genes: a simple, economical and rapid method for histocompatibility testing. Hum Immunol 1992; 33: 98-107.
72. Carrington M, Miller T, White M et al. Typing of HLA-DQA1 and DQB1 using single strand conformation polymorphism. Hum Immunol 1992; 33: 208-212.
73. Pursall MC, Clay TM, Bidwell JL. Combined PCR-heteroduplex and PCR-SSCP analysis for matching of HLA-A, -B, -C allotypes in marrow transplantation. Eur J Immunogenet 1996; 26: 41-53.
74. Novack DF, Casna NJ, Fischer SG, Ford JP. Detection of single base-pair mismatches in DNA by chemical modification followed by electrophoresis in 12% polyacrylamide gel. Proc Natl Acad Sci USA 1986; 83: 586-590.
75. Wang Y-H, Griffith J. Effects of bulge composition and flanking sequence in kinking of DNA by bulged bases. Biochemistry 1991; 30: 1358-1363.
76. Bidwell JL, Hiu K. Human HLA-dr/Dw allotype matching by analysis of HLA-DRB gene PCR product polymorphism (PCR 'Fingerprints'). Technique 1990; 2: 93-100.
77. Clay TM, Bidwell JL, Howard MR, Bradly BA. PCR-Fingerprinting for selection of HLA matched unrelated marrow donors. Lancet 1991; 337: 1049-1052.
78. Bidwell JL, Clay TN, Wood NAP et al. Rapid HLA-DR-Dw matching by PCR fingerprinting and related DNA heteroduplex technologies. In: Hui K, Bidwell JL (eds). Handbook of HLA Typing Techniques. London: CRC Press, 1993: 99-115.
79. Avakian H, Forde H, Baker F et al. Relevance of DNA heteroduplex crossmatching in the selection of bone marrow donors. Hum Immunol 1994; 40(suppl 1): 114(Abstr).
80. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-5467.
81. Santamaria P, Boyce-Jacino MT, Linstrom AL et al. HLA class II 'typing': direct sequencing of DRB, DQB and DQA genes. Hum Immunol 1992; 33: 69-81.
82. Rozemuller EH, Bouwens-Rombouts AGM, Bast EJEG, Tilanus MGJ. Assignment of HLADPB alleles by computerised matching based upon sequence data. Hum Immunol 1993; 37: 207-212.
83. Versluis LF, Rozemuller E, Tonks S et al. High resolution HLA-DPB typing based upon computerised analysis of data obtained by fluorescent sequencing of the amplified polymorphic exon 2. Hum Immunol 1993; 38: 277-283.
84. Spurkland A, Knutsen I, Markussen G et al. HLA matching of unrelated bone marrow transplant pairs: direct sequencing of in vitro amplified HLA-DRB1 and -DQB1 genes using magnetic beads as solid support. Hum Immunol 1993; 41: 155-164.
85. Rozemuller EH, Tilanus MGJ. A computerised method to predict the discriminatory properties for class II sequence based typing. Hum Immunol 1995; 46: 27-34.
86. Petersdorf EW, Hansen JA. A comprehensive approach for typing the alleles of the HLA-B locus by automated sequencing. Tissue Antigens 1995; 46: 73-85.
87. Blasczyk R, Hahn U, Wehling J et al. Complete subtyping of the HLA-A locus by sequence-specific amplification followed by direct sequencing or single-strand conformation polymorphism analysis. Tissue Antigens 1995; 46: 86-95.
88. Arguello R, Pay AL, Gallardo D et al. Complementary strand analysis: a new approach for allelic separation in complex polyallelic genetic systems. Nucl Acid Res, in press.
89. Arguello R, Avakian H, Goldman JM, Madrigal JA. A novel method for simultaneous high resolution identification of HLA-A, HLA-B and HLA-Cw alleles. Proc Natl Acad Sci USA 1996; 93: 10961-10965.
90. Madrigal JA, Arguello R, Gallardo D et al. High resolution HLA class I and II typing for unrelated bone marrow donors. Eur J Immunogenet 1997; 24: 70 (Abstr).
91. Scott I, Bunce M, Arguello R et al. How well do we have to match in BMT? Eur J Immunogenet 1995; 22: 36 (Abstr).
92. Spencer A, Szydlo RM, Brookes PA et al. Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient. Blood 1995; 86: 3590-3597.
93. Petersdorf EW, Longton GM, Anasetti C et al. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood 1997; 89: 1818-1823.
94. Davies SM, Shu XO, Blazar BR et al. Unrelated donor bone marrow transplantation: influence of HLA A and B incompatibility on outcome. Blood 1995; 86: 1636-1642.
95. Petersdorf EW, Longton GM, Anasetti C et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood 1995; 86: 1606-1613.
96. Hansen JA. Unrelated donor marrow transplants for patients with chronic myeloid leukemia. Blood 1995; 123a: (Abstr 479).
97. Barnardo M, Davey N, Bunce M et al. A correlation between HLA-C matching and donor antirecipient CTL precursor frequency in bone marrow transplantation. Transplantation 1996; 61: 1420-1423.
98. Petersdorf EW, Longton GM, Anasetti, et al. Definition of HLA-DQ as a transplantation antigen. Proc Natl Acad Sci USA 1996; 93: 15358-15363.
99. Santamaria P, Reinsmoen NL, Lindstrom AL et al. Frequent HLA class I and DP sequence mismatches in serologically (HLA-A, HLA-B, HLA-DR) and molecularly (HLA-DRB1, HLA-DQA1, HLA-DQB1) HLA-identical unrelated bone marrow transplant pairs. Blood 1994; 83: 280-287.
100. Pawelec G, Ehninger G, Schmidt H, Wernet P. HLA-DP matching and graft-versus-host disease in allogeneic bone marrow transplantation [published erratum appears in Transplantation 1987 Apr; 43(4): 608] Transplantation 1986; 42: 558-560.
101. Petersdorf EW, Hanson JA, Mickelson EM et al. The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation. Blood 1993; 81: 1923-1932.